Search

everythinglearnresearchcommunity

for

Search:↓

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Mint water extract boosts protective enzymes in skin cells.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Keratins are crucial for cell structure, growth, and disease risk.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Dermal macrophages might help regrow hair.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

Both mouse and rat models are effective for testing alopecia areata treatments.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Genomic approach finds new possible treatments for hair loss.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

The study identified key immune cell differences between mild and severe alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Clonally expanded CD8+ T cells cause alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Targeting regulatory T cells may help treat age-related diseases.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.